AI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis. Njei B, Tanih DN, Al-Ajlouni YA, Boateng S, et al. Dig Dis Sci 2026;71:3476-3488.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Njei B, Tanih DN, Al-Ajlouni YA, Boateng S, et al. AI-Based Screening for At-Risk MASLD and Advanced Fibrosis in the US Population: A Cost-Effectiveness Analysis. Dig Dis Sci 2026;71:3476-3488.
PMID: 41806252